Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 2.1 EX-2.1
- 3.1 EX-3.1
- 3.2 EX-3.2
- 4.1 EX-4.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 23.1 EX-23.1
CING similar filings
Filing view
External links
Exhibit 10.17
Mr. Edward Dresch
Dresch Inc.
[**]
[**]
Dear Mr. Dresch,
The undersigned parties to Promissory Note dated January 27, 2020 (the “Note”), by and between Edward Dresch (“Lender”), and Cingulate Therapeutics LLC (“Borrower”), for a total principle of $500,000.00 hereby mutually agree to amend said Note to change the Paid in Full dated to “February 1, 2022”. All other items of the Contract shall remain in full force and effect.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first set forth above.
BORROWER | LENDER | |||
Cingulate Therapeutics, LLC | Dresch, Inc. | |||
By: | /s/Craig S. Gilgallon | By: | /s/ Edward Dresch | |
Craig S. Gilgallon, Esq. | Edward Dresch | |||
General Counsel | President |